Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

-0.680%
-0.2
-0.680%
-
 
09:32 / Stuttgart Stock Exchange WKN: A12FU4 / Symbol: ASTM / Name: Vericel / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Vericel Corp. Stock

Vericel Corp. shows a slight decrease today, losing -€0.200 (-0.680%) compared to yesterday.
So far the community has only identified positive things for Vericel Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Vericel Corp. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Vericel Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Vericel Corp. -0.680% -7.333% -6.081% -20.571% -12.025% -9.150% -37.668%
Rockwell Medical Inc. -3.310% -6.154% -16.438% -28.024% -9.830% -82.319% -92.511%
Pacira Pharmaceuticals 0.000% -7.143% -9.722% -13.717% -9.722% -45.531% -61.000%
Twist Bioscience Corp 2.720% 8.211% 21.327% 122.239% 116.732% 296.323% -28.126%

Comments

Sell Vericel Corp.
Show more

News

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More: https://cdn.content.foolcdn.com/images/1umn9qeh/production/f5acfa2370b69ef05efd688fbbc9e56e546c0092-1401x1251.png?w=800&q=75&fit=max&auto=format
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More

Soleus Capital Management disclosed a significant buy of Vericel (NASDAQ:VCEL), adding 1,785,079 shares in the first quarter—an estimated $63.40 million trade based on quarterly average

Vericel Q1 Earnings Call Highlights
Vericel Q1 Earnings Call Highlights

Vericel (NASDAQ:VCEL) reported record first-quarter revenue and raised its full-year 2026 outlook, citing strong growth across its MACI cartilage